Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots.
暂无分享,去创建一个
[1] Y. Nishioka,et al. Lymphatic targeting with nanoparticulate system. , 2001, Advanced drug delivery reviews.
[2] T. Mihaljevic,et al. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping , 2004, Nature Biotechnology.
[3] Tonghua Wang,et al. Translocation and fate of multi-walled carbon nanotubes in vivo , 2007 .
[4] J. Riviere. Pharmacokinetics of Nanomaterials , 2007 .
[5] Jim E Riviere,et al. Biodistribution of quantum dot nanoparticles in perfused skin: evidence of coating dependency and periodicity in arterial extraction. , 2007, Nano letters.
[6] E. Nakamura,et al. In vivo biological behavior of a water-miscible fullerene: 14C labeling, absorption, distribution, excretion and acute toxicity. , 1995, Chemistry & biology.
[7] Steven A Curley,et al. Mammalian pharmacokinetics of carbon nanotubes using intrinsic near-infrared fluorescence , 2006, Proceedings of the National Academy of Sciences.
[8] Xiao Zhang,et al. Biodistribution of functionalized multiwall carbon nanotubes in mice. , 2007, Nuclear medicine and biology.
[9] Byron Ballou,et al. Noninvasive imaging of quantum dots in mice. , 2004, Bioconjugate chemistry.
[10] Ene I. Ette,et al. Pharmacometrics : the science of quantitative pharmacology , 2007 .
[11] H. Dai,et al. In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. , 2020, Nature nanotechnology.
[12] Steven W. Martin,et al. Pharmacokinetic Model to Describe the Lymphatic Absorption of r-metHu-Leptin After Subcutaneous Injection to Sheep , 2003, Pharmaceutical Research.
[13] A. Sbarbati,et al. In Vitro and In Vivo Study of Solid Lipid Nanoparticles Loaded with Superparamagnetic Iron Oxide , 2003, Journal of drug targeting.
[14] S. Kennel,et al. In vivo studies of fullerene-based materials using endohedral metallofullerene radiotracers. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[15] F. Wudl,et al. Pharmacokinetics of a water-soluble fullerene in rats , 1996, Antimicrobial agents and chemotherapy.
[16] G. Edwards,et al. Lymphatic transport of proteins after s.c. injection: implications of animal model selection. , 2001, Advanced drug delivery reviews.
[17] M. Bawendi,et al. Renal clearance of quantum dots , 2007, Nature Biotechnology.
[18] Chunxin Zhang,et al. Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models. , 2007, Nanomedicine : nanotechnology, biology, and medicine.
[19] Z. Xiaodong,et al. Preparation of (99m)Tc-C(60)(OH)(x) and its biodistribution studies. , 2002, Nuclear medicine and biology.
[20] Nigel J Walker,et al. Migration of intradermally injected quantum dots to sentinel organs in mice. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[21] W. Kreyling,et al. Health implications of nanoparticles , 2006 .
[22] P. Ke,et al. Carbon nanomaterials in biological systems , 2007 .
[23] Hans C. Fischer,et al. Pharmacokinetics of Nanoscale Quantum Dots: In Vivo Distribution, Sequestration, and Clearance in the Rat , 2006 .
[24] S. K. Sundaram,et al. Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[25] Hongfang Sun,et al. Biodistribution and tumor uptake of C60(OH)x in mice , 2006 .
[26] P. Williams,et al. Definition of a physiologic pharmacokinetic model of cutaneous drug distribution using the isolated perfused porcine skin flap. , 1989, Journal of pharmaceutical sciences.
[27] Jim E. Riviere,et al. Comparative Pharmacokinetics: Principles, Techniques, and Applications , 1999 .
[28] James M. Tour,et al. Tissue Sites of Uptake of14C-Labeled C60 , 1996 .
[29] John V Frangioni,et al. Intraoperative sentinel lymph node mapping of the lung using near-infrared fluorescent quantum dots. , 2005, The Annals of thoracic surgery.
[30] M. Prato,et al. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[31] Hong Ding,et al. Bioconjugated quantum rods as targeted probes for efficient transmigration across an in vitro blood-brain barrier. , 2008, Bioconjugate chemistry.
[32] Erkki Ruoslahti,et al. Nanocrystal targeting in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[33] W. Kreyling,et al. TRANSLOCATION OF ULTRAFINE INSOLUBLE IRIDIUM PARTICLES FROM LUNG EPITHELIUM TO EXTRAPULMONARY ORGANS IS SIZE DEPENDENT BUT VERY LOW , 2002, Journal of toxicology and environmental health. Part A.
[34] Steven W. Martin,et al. Lymphatic Absorption Is the Primary Contributor to the Systemic Availability of Epoetin Alfa following Subcutaneous Administration to Sheep , 2005, Journal of Pharmacology and Experimental Therapeutics.
[35] Ming-Hsien Tsai,et al. Persistent Tissue Kinetics and Redistribution of Nanoparticles, Quantum Dot 705, in Mice: ICP-MS Quantitative Assessment , 2007, Environmental health perspectives.
[36] Sanjiv S Gambhir,et al. microPET-Based Biodistribution of Quantum Dots in Living Mice , 2007, Journal of Nuclear Medicine.
[37] H. Devalapally,et al. Role of nanotechnology in pharmaceutical product development. , 2007, Journal of pharmaceutical sciences.